Clinical trial
Prognostic Significance of T Wave Alternans
NCT00006501 · Columbia University, Other · Completed
Key facts
| NCT number | NCT00006501 |
|---|---|
| Title | Prognostic Significance of T Wave Alternans |
| Official title | The Prevalence and Prognostic Significance of T Wave Alternans in Patients With Severe Congestive Heart Failture |
| Lead sponsor | Columbia University, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Heart Diseases, Ventricular Arrhythmia, Ventricular Fibrillation, Death, Sudden, Cardiac, Heart Arrest |
| Intervention type | Procedure |
| Interventions | ECG |
| Enrollment | 549 |
| Start date | Jan 1, 2003 |
| Primary completion | Dec 1, 2009 |
| Completion | Feb 1, 2012 |
| First posted | Nov 17, 2000 |
| Last update posted | Dec 23, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: